PubHawk
Br J Pharmacol August 2006 PMID 16783415

Mechanism of action of benzodiazepines on GABAA receptors.

Claudia Campo-Soria, Yongchang Chang, David S Weiss

Full text PDF Download social card

Mentions

3
Peak: 2 in Jul 2024
across 2 sources since Oct 2020

Extended reach

1,419
potential audience

Total likes

39

Video views

1,278

Mentions per month

Oct 2020 – Jul 2024

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

The overall discussions reflect a balanced curiosity about the mechanisms of benzodiazepines, with mentions of specific receptor mutations and their effects, illustrating engagement with technical content. Words like 'interesting,' 'important,' and references to the study's detailed findings demonstrate a moderate level of interest and understanding, though the tone remains analytical rather than emotional or transformational.

AgreementModerate agreement

Most discussions acknowledge the importance of understanding benzodiazepines' mechanisms, with some expressing support for the study’s insights into receptor mutations.

InterestModerate interest

The posts show moderate curiosity, highlighting specific aspects like mutations and receptor response, but lack strong enthusiasm.

EngagementModerate engagement

Comments often reference the technical details, such as spontaneous receptor openings and drug efficacy, indicating some depth, but overall engagement remains moderate.

ImpactNeutral impact

While some users see potential implications for pharmacology and treatment, many view the publication as primarily academic with limited immediate impact.

Abstract in brief

  • This study examined how benzodiazepines like diazepam (DZP) and methyl67dimethoxy4ethylbetacarboline3carboxylate (DMCM) affect GABAA receptors with specific mutations, finding that these drugs modulate receptor activity differently depending on the mutation and the receptor's baseline properties.
  • Mutations such as L259S in the beta subunit and L263S in the alpha subunit cause spontaneous opening of GABAA receptors and alter their response to benzodiazepines, often reducing or changing the drugs' effectiveness in shifting the GABA dose-response relationship.
  • In wildtype receptors, DZP can activate currents directly, while DMCM tends to decrease baseline activity; the effectiveness of DZP was similar across wildtype and mutated receptors, with EC50 values in the nanomolar range, indicating consistent potency.
Read the full abstract

Top posts

Most liked on X and Bluesky
Cerue
@Charalyse · X

@Jus_De_Pute https://t.co/lMz7rY6OB9

Oct 24, 2020 · 141 followers View post →

All mentions

Cerue
@Charalyse · X

@Jus_De_Pute https://t.co/lMz7rY6OB9

Oct 24, 2020 · 141 followers View post →